Biocon declines on recalling 5,505 bottles of Simvastatin tablets in US

21 Apr 2016 Evaluate

Biocon is currently trading at Rs. 557.50, down by 9.40 points or 1.66% from its previous closing of Rs. 566.90 on the BSE.

The scrip opened at Rs. 566.00 and has touched a high and low of Rs. 566.00 and Rs. 557.00 respectively. So far 30846 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 5 has touched a 52 week high of Rs. 574.25 on 20-Apr-2016 and a 52 week low of Rs. 396.50 on 25-Aug-2015.

Last one week high and low of the scrip stood at Rs. 574.25 and Rs. 549.30 respectively. The current market cap of the company is Rs. 11205.00 crore.

The promoters holding in the company stood at 60.72% while Institutions and Non-Institutions held 19.35% and 17.99% respectively.

Biocon Inc, part of biotechnology major Biocon, is recalling 5,505 bottles of cholesterol lowering Simvastatin tablets from the US market for being sub-potent. The Class III recall for 5mg tablets of simvastatin pertains to a specific lot manufactured by Blu Caribe, Puerto Rico, USA for Blu Pharmaceuticals, Kentucky, USA (together 'Blu') long before Biocon acquired the simvastatin ANDA from Blu. The FDA notified Biocon as it is the current holders of the ANDA.

Biocon is India’s largest and Asia’s leading Biotechnology Company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation-driven biopharma enterprise offering affordable solutions for chronic diseases to patient's worldwide.

 

Biocon Share Price

390.25 -5.00 (-1.27%)
29-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1717.50
Dr. Reddys Lab 1268.60
Cipla 1494.40
Zydus Lifesciences 904.00
Lupin 2079.50
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×